Downregulation of Wnt signaling pathway and mir335 through mir335 in MSCs from osteoarthritis patients  by Fernandez-Gutierrez, B. et al.
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S241453
HIP BONE MARROW LESIONS IN ASYMPTOMATIC AND
OSTEOARTHRITIC ADULTS: PREVALENCE, RISK FACTORS AND
SIGNIFICANCE
L. Dawson y, Y. Wang y, A.E. Wluka y, K. Bennell z, F.M.
Cicuttini y. yMonash Univ., Melbourne, Australia; zUniv. of Melbourne,
Melbourne, Australia
Purpose: Bonemarrow lesions (BMLs) at the knee have an important role
in thepathogenesis of osteoarthritis (OA), being associatedwith increased
pain, accelerated cartilage loss, and increased risk of total knee replace-
ment. However, data is limited for the role of BMLs at the hip. Therefore,
this study aimed to determine the prevalence and associations of BMLs at
the hip in an asymptomatic and an osteoarthritic population.
Methods: 142 asymptomatic and 19 participants with hip OA were
recruited from existing cohorts. Hip magnetic resonance imaging was
performed and used to assess femoral head BMLs, cartilage volume and
bone area.
Results: The demographic characteristics of the asymptomatic versus
the OA population were as follows: age 66.8 +/- 7.4 vs. 59.5 +/- 7.6 years
(p<0.001), female 55.6% vs. 57.9% (p¼0.85), bodymass index 27.6 +/- 4.8
vs. 27.2.+/-.4.8 kg/m2 (p¼0.73). The prevalence of BMLs was 17.6% in the
asymptomatic population and 63.2% in the OA population (p<0.001).
BMLs were strongly associated with OA after adjusting for age, gender
and body mass index (odds ratio 5.32, 95% CI 1.78, 15.9, p¼0.003). BMLs
were associated with lower femoral head cartilage volume in the whole
population (regression coefﬁcient -245.7 mm3, 95% CI -455.5, -36.0,
p¼0.02). In the OA population, BMLs were also associated with lower
femoral head cartilage volume (regression coefﬁcient -426.6 mm3, 95%
CI -855.2, 2.14, p¼0.05) after adjusting for age, gender, body mass index,
femoral head bone area and hip OA (for analysis of the total population).
Conclusion: Femoral head BMLs are common in those with OA, but are
also present in asymptomatic individuals with no clinical hip OA. They
are associated with reduced hip cartilage volume. These ﬁndings
suggest that BMLs at the hip may provide a novel target for the treat-
ment and prevention of hip OA.
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HYDROGEN SULFIDE DONORS ALLEVIATE IL-1b INDUCED
INFLAMMATION-LIKE EFFECTS IN HUMAN ARTICULAR
OSTEOARTHRITIC CHONDROCYTES
E.F. Burguera y,z, A. Vela-Anero z,x, R. Meijide-Failde x, F.J.
Blanco y,z. y INIBIC-Hosp. A Coruña, Rheumatology Div., A Coruña, Spain;
z Tissue Engineering and Cellular Therapy Group (CBTTC-CHUAC), CIBER-
BBN/ISCIII, A Coruña, Spain; xCell Therapy and Regenerative Med. Group,
Dept. of Med., Univ. of A Coruña, A Coruña, Spain
Purpose: Hydrogen sulﬁde, H2S, has been recently recognized as an
important signaling molecule. Once exclusively thought of as a toxic
gas, it is now being considered as the third gas transmitter together
with NO and CO. H2S has been found to be implicated in many
inﬂammatory pathologies and there are studies that suggest that it can
act as an anti-inﬂammatory and anti-oxidant agent. In the present
study, we analyzed the inﬂuence of two H2S donors (NaHS and
GYY4137) on several aspects that characterize the inﬂammatory process
in osteoarthritis (OA). Speciﬁcally we looked at: 1) Nitric oxide (NO)
production and inducible NO synthase (iNOS) levels; 2) Production of
reactive oxygen species (ROS) and antioxidant enzyme superoxide
dismutase 2 (SOD2); 3) The production of prostaglandin E-2 (PGE-2);
and 4) Levels of matrix metalloproteinase 3 (MMP3).
Methods: Primary human chondrocytes were isolated from OA tissue.
Cells were stimulated with a pro-inﬂammatory cytokine (interleukin-1b,
IL-1b, 5ng/ml) andwe used different concentrations (ranging from50 mM
to 1000 mM) of the two H2S donors to investigate their ability to
ameliorate the effects of IL-1b on the cells. NO productionwas quantiﬁed
through the Griess reaction. Protein levels were visualized through
immunocytochemistry and quantiﬁed with appropriate software; mRNA
expression levelswere detectedwithqRT-PCR. ROS levelswere quantiﬁed
with a ﬂuorescence microscope after DCFH or dihydrorhodamine 1,2,3
treatment. PGE-2 levels were measured with a speciﬁc EIA.
Results: Treatment with IL-1b caused an increase in NO and PGE-2
production, iNOS protein levels, and SOD2 and MMP3 mRNA and
protein levels. GYY4137 and NaHS treatment was effective in reducing
NO production down to 25% and 50% of the stimulated values
(respectively), although none were able to recover the non stimulatedstate (Figure 1A). Even though H2S might react directly with it, NO
reduction was probably the result of a decline in iNOS stimulation,
because iNOS protein levels were also reduced by both GYY4137 and
NaHS treatment. H2S released by GYY4137 and NaHS probably reacts
directly with the ROS present in the OA cells and we saw a reduction in
both mRNA and protein levels of SOD2 in the stimulated cells. These
effects were also accompanied by a reduction in PGE-2 levels: all
GYY4137 concentrations led to about a 60% reduction in PGE-2 in the
stimulated cells and low NaHS concentrations (50-200mM) to about
a 75% reduction (Figure 1B). We also saw reductions in both MMP3
mRNA and protein levels after treatment with the H2S donors.
Conclusions: Results obtained so far suggest that there might be
a therapeutic window for H2S donors that show anti-inﬂammatory and
antioxidant properties. This might be of interest in the alleviation of OA-
induced inﬂammation processes and it should be further explored.
Figure 1. Effect of different concentrations of H2S donors NaHS and GY4137 on (A) NO
and (B) PGE-2 production in IL-1b stimulated human articular osteoarthritic chon-
drocytes.
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DOWNREGULATION OF WNT SIGNALING PATHWAY AND MIR335
THROUGH MIR335 IN MSCS FROM OSTEOARTHRITIS PATIENTS
B. Fernandez-Gutierrez, P. Tornero-Esteban, J.R. Lamas, E.
Villafuertes, A. Peralta-Sastre, M. Hernandez-Molinero, J.A.
Hoyas. UGC de Reumatología, Hosp. Clínico San Carlos, Inst. de
Investigación Sanitaria del Hosp. Clínico San Carlos (IdISSC), Madrid,
Spain., Madrid, Spain
Purpose:Wnt signallingpathway regulatesmesenchymal stem cell (MSC)
self-renewalanddifferentiation. Inosteoarthritis (OA)theWntsignalling is
altered in MSCs isolated from the bone marrow (BM-MSC) and likely
contributing to OA pathogenesis. miRNAs are critical regulators of
mesenchymal stem biology and overexpression of speciﬁc miRNA
(mir335),which inaddition isupregulatedby theWnt/b-catenin signalling
pathway, has been shown to inhibit osteogenic differentiation. According
to these evidences, the aim of this study was to delineate the effect over
Wnt genes after mir335 overexpression in BM-MSCs from OA patients.
Methods: RNA samples from BM-MSC of three OA patients and three
controls were analyzed by quantitative PCR to determine the expression
of mir335 and MEST gene (which controls mir335 expression). The effect
of mir335 overexpression in Wnt signaling was determined using a GFP
gene reporter assay of BM-MSC transduced with a lentiviral vector con-
tainingmir335 and GFP in one OA patient. Transducted (GFP+) cells were
puriﬁed 48h after transduction by ﬂuorescence-activated cell sorting
(FACS). Transducted GFP cells as well as non-transducted cells were used
as control. Cells were further induced to osteogenic differentiation and
studied at 0,10 and21days. Simultaneous expression of 84Wnt signalling
pathway related genes were analyzed by a PCR Array proﬁling.
Results: miR335 expression levels was reduced by about 50% in OA
patients compared to expression levels found in controls. As expected,
MEST gene was also clearly downregulated. A different behaviour was
observed during differentiation to osteoblast lineage. At initial stages
(0-10 days) BM-MSC transducted withmir335 showed an up-regulation
of 16 Wnt signalling pathway related genes. Interestingly, seven out of
the 16 were downregulated in the non-transduced cells. These genes
includes the PITX2, SFRP1, SFRP4,WIF1,WNT16, WNT2 and WNT6.
Towards the terminal stage of bone forming cells (10-21) days, a marked
reduction of gene expression was detected in comparison to control
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the, canonical, planar, Cell Growth & Proﬁleration and Cell Migration,
were identiﬁed. One of them, DAAM1, have been already described as
direct targets of mir-335.
Conclusions: Our results indicate a lower expression of mir335 in OA-
MSCs patients and suggest that the downregulation in Wnt related
genes during the initial stages of differentiation that could be partly
restored after mir335 overexpression. Therefore, we hypothesize that
a diminished expression of mir335 could contribute to the altered
function of MSCs in OA.
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LONGITUDINAL RATES OF CHANGE IN SUBCHONDRAL BONE SIZE IN
HEALTHY KNEES AND KNEES WITH RADIOGRAPHIC
OSTEOARTHRITIS
M. Hudelmaier y, W. Wirth y, M. Nevitt z, F. Eckstein y. for the OAI
investigatorsy Paracelsus Med. Univ., Salzburg, Austria; zUniv. of
California, OAI Coordinating Ctr., San Francisco, CA, USA
Purpose: Several studies reported that an increase of subchondral bone
area (tAB) is associatedwith features of radiographic knee osteoarthritis
(rOA), such as osteophytes, joint space narrowing or subchondral
defects. One cross-sectional study reported that tABs were larger in
knees with higher KL grades, based on site readings from the OA
initiative (OAI). Here we test the hypotheses that knees with rOA show
greater rates of longitudinal tAB change than knees with risk factors but
not deﬁnite radiographic OA (pre-rOA) or healthy knees without.
Methods: Coronal FLASHwe MR images of 899 right knees from OAI
participants (539 women, 360 men; age 61.69.5; BMI 28.94.8) were
acquired at baseline and 12 month follow-up (public use datasets 0.E.1
and 1.E.1). Based on central radiographic readings (Boston University),
101 knees were classiﬁed asymptomatic healthy controls (bilateral KLG
0, no OA risk factors), 254were pre-rOA (KLG 0&1, with risk factors), and
544 had deﬁnite rOA (KLG 2-4). The tAB of the medial and lateral tibia
(MT/LT) and weight-bearing (central) femoral condyles (cMF/cLF) were
segmented by experienced readers, by matching numbers of slices
processed per plate in scan pairs, but with blinding to acquisition order.
The size of the tAB was calculated in 3D. Because an increase in tAB was
expected, 1-sided non-paired t-tests were used to compare groups, and
signiﬁcance of change was assessed with 1-sided paired t-tests.
Results: tAB changes were less than 1% in all strata (Table 1) and were
not signiﬁcantly different from zero in healthy reference knees (SRM
range -0.10 to +0.11). Pre-rOA knees had a signiﬁcant (p<0.05) tAB
increase in cMF (SRM +0.10) but not in other plates (SRM 0.05). rOA
knees showed signiﬁcant tAB increases in MT (SRM +0.14), cMF (SRM
+0.21) and cLF (SRM +0.15), but not in LT (SRM +0.03). The changes were
signiﬁcantly greater than in rOA than in pre-rOA knees for MT and cLF
(p< 0.05), and greater than in healthy controls for MT (p<0.05). In MT,
the percent increase in tAB was greater in knees with higher KL grades.
Conclusions: Knees with deﬁnite rOA show small but signiﬁcant
longitudinal increases in tAB, predominantly in the medial compart-
ment. In the medial tibia, the rate of tAB changewas greater in rOA than
in pre-rOA or healthy knees. The observed relationship between tAB
change and rOAI status in the medial tibia may be due to rOA
predominantly affecting the medial compartment (in general and in the
OAI) and because femorotibial loading is known to be greater medially
than laterally. The current results suggest that longitudinal change in
tABs is a feature of structural progression associated with rOA status.Table 1
Change in the subchondral bone area (tAB [Mean%SEM]) over 12 months in OAI
knees
Group Size MT LT cMF cLF
Healthy n¼101 -0.11.2% -0.11.2% 0.21.1% 0.00.9%
Pre-rOA n¼254 0.00.8% 0.10.7% 0.20.6% 0.00.5%
KLG2 n¼316 0.10.7% 0.10.7% 0.30.5% 0.20.5%
KLG3 n¼167 0.21.1% 0.11.0% 0.50.9% 0.20.8%
KLG4 n¼61 0.32.1% -0.11.9% 0.31.5% 0.31.1%457
PPARa SIGNALLING REDUCES SUBCHONDRAL BONE THICKENING
AND INFLAMMATION, BUT DOES NOT PREVENT CARTILAGE
DAMAGE IN STR/ORT MICEW. Wei y, S. Botter y,z, Y. Bastiaansen-Jenniskens y, L. Gierman k,x, S.
Bierma-Zeinstra y, J. Verhaar y, H. Weinans y, A.-M. Zuurmond x, S.
Clockaerts y,{, G. Van Osch y. y Erasmus Univ. Med. Ctr., Rotterdam, The
Netherlands; zUniv. Hosp. Balgrist, Zurich, Switzerland; x TNO, Leiden,
The Netherlands; k Leids Univ. Med. Ctr., Leiden, The Netherlands; {Univ.
of Antwerp, Antwerp, Belgium
Purpose: Subchondral bone changes are an important feature in oste-
oarthritis (OA). Initial loss of bone volume (BV) followed by sclerosis and
thickening of the subchondral bone plate occur during OA develop-
ment. STR/Ort mice have been suggested to develop OA spontaneously
due to reduced endogenous PPARa signalling, possibly by increasing
inﬂammatory processes in the joint and an altering osteoblast pheno-
type [Watters 2007, Arthritis Rheum]. To conﬁrm the role of PPARa in
the development of OA, we have treated STR/Ort mice with fenoﬁbrate,
a PPARa agonist, and evaluated inﬂammation, subchondral changes and
OA cartilage damage in this spontaneous OA model.
Methods: 8-weeks-old male STR/Ort mice (n¼36) were divided into 3
experimental groups (n¼12 per group). One group received reference
diet (Control) whereas the other 2 groups received reference diet mixed
with two different dosages of fenoﬁbrate (100mg/kg bodyweight (BW)/
day or 200 mg/kg BW/day). Mice were euthanized after 16 weeks of
treatment at the age of 6 months. mCT was used to quantify subchondral
bone volume (Sb.BV) in a pre-deﬁned region of interest and sub-
chondral plate thickness (Sb.Th), in addition to metaphyseal bone
volume fraction (BV/TV), trabecular thickness (Tb.Th), trabecular
number (Tb.N) and trabecular separation (Tb.Sp). Level of inﬂammation
was determined by measuring serum amyloid A (SAA). Knee cartilage
damage was evaluated by histology using the OARSI scoring method.
Results: Mice treated with 200 mg/kg BW/day fenoﬁbrate had a signiﬁ-
cantly lower amount of subchondral bone, with lower Sb.BV and Sb.Th, as
well as a lower amount of metaphyseal bone, with lower BV/TV and Tb.N
and elevated Tb.Sp. No signiﬁcant difference in cartilage damage was
found between the groups. Fenoﬁbrate treated mice had signiﬁcantly
lower levels of SAA compared to Control. Although no difference was
found in SAA levels between mice with and without cartilage damage,
reduced SAA was associated with less Sb.BV, BV/TV and Tb.Th.
Conclusions: Systemic inﬂammation and subchondral bone volume
and thickness in the STR/Ort mouse can be reduced by fenoﬁbrate
treatment. However, cartilage damagewas not inﬂuenced. This suggests
that PPARa signalling may inﬂuence subchondral bone morphology, but
is not correlated with cartilage damage in the STR/Ort mouse.
Acknowledgment: ﬁnancial support of Top Institute Pharma (grant T1-
213-1), Anna Fonds and Nuts Ohra
Figure. Effect of treatment on (A) subchondral bone volume and (B) plate thickness,
(C) cartilage damage and (D) serum amyloid A levels. Indicated dosage is mg/kg
bodyweight/day.
